Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-073813
Filing Date
2025-05-16
Accepted
2025-05-16 18:41:55
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4030
  Complete submission text file 0000950170-25-073813.txt   5475
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VENTYX BIOSCIENCES, INC. 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address
Gonzales Roy (Reporting) CIK: 0002035970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 25961069